Comanche Biopharma
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate the Safety, Pharmacodynamic and Pharmacokinetic Characteristics of CBP-4888 in Hospitalized Participants With Preterm Preeclampsia and Their Children up to 24 Months (NCT07282171) | Comanche Biopharma | 2025-02-26 |
| Study of CBP-4888 in Healthy, Non-Pregnant Female Subjects (NCT05881993) | Comanche Biopharma | 2023-05-22 |
Track Comanche Biopharma automatically
Every clearance here is in the API, with alerts when new ones post.